The Ohio State University Center for Continuing Medical Education (OSUCCME) 2026 Hematology Symposium

This conference is designed for a diverse audience including physicians, nurses, researchers, residents, and industry professionals. The symposium will delve into current clinical research available to patients at The James and nearby communities. It will identify gaps in practice, discuss the introduction of novel therapies for relapsed diseases, and cover the understanding of toxicities and tolerance. Additionally, it will evaluate advances in oncology care and assess biomarkers for treatment decisions. **Learning Objectives:** 1. Describe evidence-based therapies for hematological diseases. 2. Describe the use of biomarkers in hematological disease diagnosis. 3. Identify factors necessitating early interventions in hematological patients. 4. List risk factors for severity and mortality in these diseases. 5. Explain mechanisms and risks associated with novel hematological treatments.